Research

Find evidence—and understand what it means.

Research headlines rarely tell the whole story. Start with the study type, who participated, what was measured, and what questions remain.

Educational exploration

Explore the NF Body

Choose a body system or a whole-person concern to explore possible NF connections, questions researchers study, and reviewed starting points. NF affects every person differently; an item appearing here does not mean that every person with NF will experience it.

Interactive diagram

Choose an area of the body

Select a marker to open its educational overview and research-question shortcut.

A simplified body outline used to position interactive educational markers. Use the labeled buttons or the cards below.

Selected starting point

Brain & nervous system

Explore tumors of the brain, spine, and nerves, neurologic changes, headaches, seizures, and related monitoring or research questions.

Topics you may encounter

  • Brain and spinal tumors
  • Peripheral nerves
  • Headaches and seizures
  • Neurologic function

Relevant across

  • NF1
  • NF2-related schwannomatosis
  • Other schwannomatosis types
Open reviewed overview

Browse without the diagram

Body areas and systems

7 starting points

Explore beyond one body part

Symptoms and whole-person concerns

5 starting points

Selected starting point

Brain & nervous system

Explore tumors of the brain, spine, and nerves, neurologic changes, headaches, seizures, and related monitoring or research questions.

Topics you may encounter

  • Brain and spinal tumors
  • Peripheral nerves
  • Headaches and seizures
  • Neurologic function

Relevant across

  • NF1
  • NF2-related schwannomatosis
  • Other schwannomatosis types
Open reviewed overview

Reviewed starting points: The body-system and whole-person summaries use current GeneReviews chapters for NF1, NF2-related schwannomatosis, and LZTR1- and SMARCB1-related schwannomatosis. They are navigation aids, not complete lists of manifestations, surveillance recommendations, or treatment guidance.